Who Owns Traws Pharma Stock?
NASDAQ: TRAWHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 40.06%
- Held by insiders
- 5.39%
- Institutional holders
- 37
- Institutions 40.1%
- Insiders 5.4%
- Public and other 54.5%
Who owns Traws Pharma stock?
Institutional investors own about 40.1% of Traws Pharma's shares, spread across 37 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 5.39% of TRAW.
The largest institutional holders are Orbimed Advisors LLC. (7.83%), Ally Bridge Group (NY) LLC (5.12%) and Adage Capital Partners GP L.L.C. (4.75%). Together, the top 10 institutions control 35.6% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their TRAW positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of TRAW
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Orbimed Advisors LLC. | 1.20M | 7.83% | +98.7% |
| Ally Bridge Group (NY) LLC | 786.24K | 5.12% | +100.0% |
| Adage Capital Partners GP L.L.C. | 730.00K | 4.75% | 0.0% |
| Adar1 Capital Management, LLC | 597.73K | 3.89% | +287.9% |
| Lynx1 Capital Management Lp | 559.47K | 3.64% | +3610.5% |
| Ikarian Capital, LLC | 478.14K | 3.11% | -29.5% |
| Sphera Funds Management Ltd. | 398.49K | 2.59% | +100.0% |
| Vanguard Capital Management LLC | 330.05K | 2.15% | +498.0% |
| Jane Street Group, LLC | 216.01K | 1.41% | +916.9% |
| Alyeska Investment Group, L.p. | 164.38K | 1.07% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of TRAW
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 177.20K | 1.15% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 152.85K | 0.99% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 73.91K | 0.48% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 17.60K | 0.11% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 8.10K | 0.05% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 7.47K | 0.05% |
| Blackstone Alternative Investment Fd.s-Blackstone Alternative Multi-St | 11 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Traws Pharma?
Orbimed Advisors LLC. is the largest institutional shareholder of TRAW, owning 7.83% of shares outstanding (1.20M shares) as of its latest 13F filing.
What percentage of Traws Pharma is owned by institutions?
Institutions own about 40.1% of TRAW shares and 42.3% of the public float.
How much of Traws Pharma do insiders own?
Insiders, such as officers and directors, own about 5.39% of TRAW shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.